News & Events
Events
-
September 20, 2016 - September 23, 2016
C-Path Posters from World Parkinson’s Congress 2016
In September, Critical Path for Parkinson’s (CPP) participated in the World Parkinson’s Congress in Portland, Oregon. This meeting brought together people living with Parkinson’s disease (PD), their care partners, and leading researchers, to learn of current advances in PD research and therapies. The 2016 conference saw 4,555 registrants from 67 countries: 40% neuroscientists, clinicians, researchers,... -
September 12, 2016 - September 13, 2016
Applying Regulatory Science to Neonates: Second Annual Scientific Workshop at European Medicines Agency (EMA)
Date: September 12-13, 2016 Location: European Medicines Agency, Canary Wharf, London Sponsors: Critical Path Institute and European Medicines Agency The International Neonatal Consortium (INC) organized a two day workshop at the European Medicines Agency (EMA) on September 12-13, 2016. Focused on applying regulatory science to neonates, INC members explored approaches that family and neonatal nursing... - July 14, 2016
-
June 18, 2016
Critical Path for Parkinson’s (CPP) members met on June 18th in Berlin for the First Annual Consortium Member Meeting
Critical Path for Parkinson’s (CPP) members met on June 18th in Berlin for the First Annual Consortium Member Meeting. A group of 34 world leading experts from industry, academia and patient advocacy organizations convened for a day to discuss the progress to date and the future scope of the multinational consortium. Themes included recognition of... -
May 26, 2016 - July 14, 2016
Current trends in BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury
The Critical Path Institute’s Predictive Safety Testing Consortium hosted a webinar series focused on BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury. Over the course of six two-hour webinars, scientists presented current data and research on clinical examples of BSEP inhibition and hepatotoxicity, in vivo tools for confirming perturbation...